Exploration of the Value of Health-Related Quality-of-Life Information From Clinical Research and Into Clinical Practice

Guyatt, Gordon H.; Ferrans, Carol Estwing; Halyard, Michele Y.; Revicki, Dennis A.; Symonds, Tara L.; Varricchio, Claudetfe G.; Kotzeva, Anna; Valderas, Jose M.; Alonso, Jordi L.
October 2007
Mayo Clinic Proceedings;Oct2007, Vol. 82 Issue 10, p1229
Academic Journal
Quality-of-life (QOL) instruments used in clinical research can provide important evidence to inform decisions about alternative treatments. This is particularly true when patients, such as those with cancer who are contemplating toxic chemotherapy, face tradeoffs between quantity of life and QOL or when the primary goal of therapy is to improve hew patients feel. Surrogate measures (cardiac function, exercise capacity, bone density, tumor size) are inadequate substitutes for direct measurement of QOL. Quality-of-life measures will be most valuable when they comprehensively measure aspects of QOL that are both important to patients and likely to be influenced by therapy, when the QOL measurement instruments are valid (measuring what is intended) and responsive (able to detect all important changes, even if small), and when the results are readily interpretable (determining whether treatment-related changes are trivial, small but important, or large). Researchers are finding new, imaginative ways to help clinicians understand the magnitude of treatment impact on QOL. Additionally, QOL measures may be useful in clinical practice. Recent results from well-designed randomized controlled trials suggest that information on patient QOL provided to clinicians might, in some circumstances, result in benefits for these patients. Further investigation is warranted to confirm these observations and to define the particular combination of methods and settings most likely to yield important benefits.


Related Articles

  • Applying Quality-of-Life Data Formally and Systematically Into Clinical Practice. Frost, Marlene H.; Bonomi, Amy E.; Cappelleri, Joseph C.; Sch√ľnemann, Holger J.; Moynihan, Timothy J.; Aaronson, Neil K. // Mayo Clinic Proceedings;Oct2007, Vol. 82 Issue 10, p1214 

    The systematic integration of quality-of-life (QOL) assessment into the clinical setting, although deemed important, infrequently occurs. Barriers include the need for a practical approach perceived as useful and efficient by patients and clinicians and the inability of clinicians to readily...

  • Precision of Health-Related Quality-of-Life Data Compared With Other Clinical Measures. Hahn, Elizabeth A.; Cella, David; Chassany, Olivier; Fairclough, Diane L.; Wong, Gilbert Y.; Hays, Ron D. // Mayo Clinic Proceedings;Oct2007, Vol. 82 Issue 10, p1244 

    To many clinicians, the assessment of health-related quality of life (HRQL) seems more art than science. This belief is due in part to the lack of formal training available to clinicians regarding HRQL measurement and interpretation. When HRQL is used systematically, it has been shown to improve...

  • Quality-of-Life Inquiries Aid Doctor Patient Relationships. Wellbery, Caroline // American Family Physician;3/15/2003, Vol. 67 Issue 6, p1381 

    Discusses the study 'Health-related Quality-of-life Assessments and Patient-Physician Communication: A Randomized Controlled Trial,' by S.B. Detmar et al., from the December 18, 2002 issue of the 'Journal of the American Medical Association.'

  • Clinical trials beyond the darker side? Damle, S. G. // Journal of the Indian Society of Pedodontics & Preventive Dentis;Mar2006, Vol. 24 Issue 1, p6 

    States that India are becoming a global hub for drug trials. Reasons why many drug trials are conducted in the country; View on doctor patient relationship; Importance of transparency in drug trials.

  • Impact of Participant and Physician Intervention Preferences on Randomized Trials: A Systematic Review. King, Michael; Nazareth, Irwin; Lampe, Fiona; Bower, Peter; Chandler, Martin; Morou, Maria; Sibbald, Bonnie; Lai, Rosalind // JAMA: Journal of the American Medical Association;3/2/2005, Vol. 293 Issue 9, p1089 

    Context Allocation on the basis of randomization rather than patient choice is the gold standard of unbiased estimates of efficacy in clinical medicine. However, randomly allocating patients to treatments that do not accord with their preferences may influence internal and external validity....

  • Estimating EQ-5D and OAB-5D health state utilities for patients with overactive bladder. Desroziers, Katia; Aball√©a, Samuel; Maman, Khaled; Nazir, Jameel; Odeyemi, Isaac; Hakimi, Zalmai // Health & Quality of Life Outcomes;2013, Vol. 11 Issue 1, p1 

    Background Limited utility data on patients suffering from overactive bladder (OAB) are available in the literature. The objectives of this study were to estimate utility values in patients with OAB using the generic EQ-5D questionnaire and the OAB-5D disease specific questionnaire, to...

  • Development of an awareness-based intervention to enhance quality of life in severe dementia: trial platform. Clare, Linda; Woods, Robert T.; Whitaker, Rhiannon; Wilson, Barbara A.; Downs, Murna // Trials;2010, Vol. 11, p73 

    Background: Quality of residential care for people with severe dementia is in urgent need of improvement. One reason for this may be the assumption that people with severe dementia are unaware of what is happening to them. However, there is converging evidence to suggest that global assumptions...

  • Allergic disease therapies key to patient quality of life. D'Arienzo, Peter // Ophthalmology Times;3/1/2005, Vol. 30 Issue 5, p1 

    The article discusses quality of life (QOL) which has become an issue in ophthalmology and other branches of medicine. The impact of QOL issues has begun to be quantified in cardiovascular disease, gastroenterology, geriatric medicine, and in all forms of allergic disease. QOL is expected to...

  • Measuring responses to therapy in headache patients: new and traditional end-points. D'Amico, D.; Grazzi, L.; Usai, S.; Rigamonti, A.; Solari, A.; Bussone, G. // Neurological Sciences;Oct2004 Supplement 3, Vol. 25, ps108 

    Changes in numerical indices of the intensity, duration and frequency of attacks are traditionally used to assess the effectiveness of treatments for migraine and other primary headaches. However, recent clinical and therapeutic guidelines and guidelines for conducting clinical trials specify...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics